XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.24.3

Accounts Payable and Accrued Expenses | 9 Months Ended
--- | ---
Sep. 30, 2024
Accounts Payable and Accrued Expenses |
Accounts Payable and Accrued Expenses |
| 4. | Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses is comprised of the following as of September 30, 2024 and December 31, 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, 2024 |  | December 31, 20231
Accrued research and development costs | ​ | $ | 8,760 | ​ | $ | 6,091
Accrued 2023 Lilly License costs | ​ | ​ | 5,000 | ​ | ​ | 10,000
Accounts payable | ​ |  | 1,014 | ​ | ​ | 2,749
Accrued bonus | ​ |  | 1,361 | ​ | ​ | 1,201
Accrued professional fees | ​ | ​ | 948 | ​ | ​ | 150
Accrued withholding taxes payable | ​ | ​ | 584 | ​ | ​ | —
Other accrued expenses | ​ | ​ | 577 | ​ | ​ | 111
Total accounts payable and accrued expenses | ​ | $ | 18,244 | ​ | $ | 20,302
(1) | Comparative figures have been reclassified to conform with current period presentation.

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration